Clinical Trial Update: Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial is examining propranolol in combination with standard chemoradiation for esophageal adenocarcinoma, currently in recruitment. The study investig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Esophageal Adenocarcinoma | Phase 2 | Status: RECRUITING